Company / PP&E per Share
Anika Therapeutics, Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$2.80
FY2025
5-year range
$2.56 / $3.34
FY2021-FY2025
Trend
+5.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share has fluctuated over the past 10 years, ranging from $2.56 in FY2023 to $3.84 in FY2017.
Based on SEC 10-K filings.
2.80 in FY2025 with a 5-year CAGR of -4.7%.
Improved from $2.56 to $2.80 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -5.8%
- 5-Year CAGR
- -4.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, pp&e per share increased 5.2% year-over-year.
- Peak pp&e per share was recorded in FY2017.
- Lowest pp&e per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.80 | +5.2% |
| FY2024 | $2.66 | +3.9% |
| FY2023 | $2.56 | -23.4% |
| FY2022 | $3.34 | +0.6% |
| FY2021 | $3.32 | -6.4% |
| FY2020 | $3.55 | -0.7% |
| FY2019 | $3.57 | -3.0% |
| FY2018 | $3.68 | -4.1% |
| FY2017 | $3.84 | +10.4% |
| FY2016 | $3.48 | +28.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026